Table 2.
Number of deaths and percentage of mortality by diseases of the respiratory system in 2020 in Spain by gender (panel A); autonomous community (panel B); and age (panel C).
| ICD-10 Causes of death | Men | Women |
|---|---|---|
| (A) By gender | ||
| 00A Covid-19 virus identified | 32.498 (13.0%)a | 27.860 (11.4%) |
| 00B Covid-19 Unidentified virus (suspected) | 6.419 (2.6%) | 8.062 (3.3%) |
| 002 Tuberculosis and its late effects | 124 (0.0%) | 74 (0.0%) |
| 018 Malignant tumour of the trachea. bronchus and lung | 16.615 (6.7%) | 5.303 (2.2%) |
| 019 Other respiratory and intrathoracic malignant tumours | 359 (0.1%) | 143 (0.1%) |
| 062 Influenza (includes influenza due to identified pandemic or zoonotic influenza viruses) | 446 (0.2%) | 448 (0.2%) |
| 063 Pneumonia | 4.704 (1.9%) | 4.064 (1.7%) |
| 064 Chronic lower respiratory tract diseases (except asthma) | 8.832 (3.5%) | 2.954 (1.2%). |
| 065 Asthma | 212 (0.1%) | 736 (0.3%) |
| 066 Respiratory insufficiency | 927 (0.4%) | 1.112 (0.5%) |
| 067 Other diseases of the respiratory system | 8.714 (3.5%) | 9.274 (3.8%) |
| Total “Causes of death due to respiratory system” | 79.850 (32.0%)b | 60.030 (24.6%) |
| 001-102 I-XXII. All causes | 249.664 (50.6%)c | 244.112 (49.4%) |
| ICD-10 Causes of death | Andalucía | Aragón | Canarias | Cantabria | Castilla – La Mancha | Castilla y León | Cataluña | Ceuta | Madrid | Navarra | Valencia | Extremadura | Galicia | Islas Baleares | La Rioja | Melilla | País Vasco | Asturias | Murcia | España |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (B) By Autonomous community. | ||||||||||||||||||||
| 00A Covid-19 Virus identified |
5821 (7.4%)*e |
2653 (15.9%)* |
403 (2.4%)* |
427 (6.5%)* |
4817 (18.4%)* |
5823 (15.9%)* |
12,871 (16.1%)* |
59 (9.3%) |
14.540 (22.0%)* |
1004 (14.9%)* |
3161 (6.5%)* |
1099 (8.5%)* |
1499 (4.6%)* |
557 (6.5%)* |
577 (15.5%)* |
43 (7.7%)* |
2.753 (11.5%)* |
1513 (10.4%)* |
738 (6.0%)* |
60,358 (12.2%) |
| 00B Covid-19 Unidentified virus (suspected) |
696 (0.9%)* |
289 (1.7%)* |
98 (0.6%)* |
68 (1.0%)* |
1683 (6.4%)* |
1889 (5.2%)* |
3013 (3.8%)* |
4 (0.6%)* |
4.817 (7.3%)* |
179 (2.7%) |
651 (1.3%)* |
290 (2.2%)* |
83 (0.3%)* |
43 (0.5%)* |
71 (1.9%)* |
4 (0.7%)* |
311 (1.3%)* |
260 (1.8%)* |
32 (0.3%)* |
14,481 (2.9%) |
| 002 Tuberculosis and its late effects | 37 (0.0%)d |
5 (0.0%) |
10 (0.1%) |
5 (0.1%) |
3 (0.0%) |
13 (0.0%) |
31 (0.0%) |
4 (0.6%)* |
11 (0.0%)* |
2 (0.0%) |
24 (0.1%) |
2 (0.0%) |
21 (0.1%) |
2 (0.0%) |
4 (0.1%) |
1 (0.2%) |
14 (0.1%) |
7 (0.0%) |
2 (0.0%) |
198 (0.0%) |
| 018 Malignant tumour of the trachea, bronchus and lung | 3539 (4.5%) | 704 (4.2%) |
963 (5.8%)* |
346 (5.3%)* |
851 (3.2%)* |
1354 (3.7%)* |
3370 (4.2%)* |
31 (4.9%) |
2.509 (3.8%)* |
326 (4.8%) |
2.561 (5.2%)* |
582 (4.5%) |
1546 (4.7%) |
491 (5.7%)* |
143 (3.8%) |
18 (3.2%) |
1193 (5.0%)* |
735 (5.0%)* |
656 (5.3%)* |
21,918 (4.4%) |
| 019 Other respiratory and intrathoracic malignant tumours | 64 (0.1%) |
13 (0.1%) |
14 (0.1%) |
13 (0.2%) |
18 (0.1%) |
45 (0.1%) |
80 (0.1%) |
1 (0.2%) |
72 (0.1%) |
13 (0.2%) |
46 (0.1%) |
8 (0.1%) |
41 (0.1%) |
8 (0.1%) |
3 (0.1%) |
0 (0.0%) |
40 (0.2%)* |
11 (0.1%) |
12 (0.1%) |
502 (0.1%) |
| 062 Influenza (includes influenza due to identified pandemic or zoonotic influenza viruses) | 172 (0.2%) |
48 (0.3%)* |
55 (0.3%)* |
18 (0.3%) |
41 (0.2%) |
44 (0.1%)* |
137 (0.2%) |
5 (0.8%)* |
67 (0.1%)* |
18 (0.3%) |
59 (0.1%)* |
11 (0.1%) |
62 (0.2%) |
10 (0.1%) |
9 (0.2%) |
1 (0.2%) |
55 (0.2%) |
47 (0.3%)* |
35 (0.3%) |
894 (0.2%) |
| 063 Pneumonia | 1301 (1.7%) |
331 (2.0%) |
497 (3.0%)* |
119 (1.8%) |
523 (2.0%) |
614 (1.7%) |
1099 (1.4%)* |
15 (2.4%) |
1.406 (2.1%)* |
97 (1.4%) |
966 (2.0%)* |
358 (2.8%)* |
499 (1.5%)* |
142 (1.7%) |
40 (1.1%)* |
26 (4.6%)* |
228 (0.9%)* |
258 (1.7%) |
249 (2.0%) |
8768 (1.8%) |
| 064 Chronic lower respiratory tract diseases (except asthma) | 1.950 (2.5%) |
400 (2.4%) |
467 (2.8%)* |
174 (2.7%) |
667 (2.5%) |
738 (2.0%)* |
1.892 (2.4%) |
20 (3.2%) |
1.334 (2.0%)* |
160 (2.4%) |
1.306 (2.7%)* |
331 (2.6%) |
841 (2.6%) |
276 (3.2%)* |
59 (1.6%)* |
12 (2.1%) |
499 (2.1%)* |
319 (2.2%) |
341 (2.8%)* |
11,786 (2.4%) |
| 065 Asthma | 152 (0.2%) |
22 (0.1%) |
28 (0.2%) |
12 (0.2%) |
58 (0.2%) |
57 (0.2%) |
154 (0.2%) |
0 (0.0%) |
73 (0.1%)* |
17 (0.3%) |
89 (0.2%) |
23 (0.2%) |
71 (0.2%) |
14 (0.2%) |
4 (0.1%) |
0 (0.0%) |
90 (0.4%)* |
63 (0.4%)* |
21 (0.2%) |
948 (0.2%) |
| 066 Respiratory insufficiency | 360 (0.5%) |
33 (0.2%)* |
54 (0.3%) |
21 (0.3%) |
95 (0.4%) |
107 (0.3%)* |
337 (0.4%) |
2 (0.3%) |
551 (0.8%)* |
19 (0.3%) |
169 (0.3%) |
38 (0.3%) |
59 (0.2%)* |
57 (0.7%)* |
8 (0.2%) |
4 (0.7%) |
63 (0.3%)* |
36 (0.2%)* |
26 (0.2%)* |
2039 (0.4%) |
| 067 Other diseases of the respiratory system |
2673 (3.4%)* |
581 (3.5%) |
853 (5.1%)* |
279 (4.3%)* |
1110 (4.2%)* |
1356 (3.7%) |
2502 (3.1%)* |
18 (2.8%) |
2858 (4.3%)* |
211 (3.1%) |
1402 (2.9%)* |
650 (5.0%)* |
1616 (4.9%)* |
237 (2.75%)* |
143 (3.8%) |
14 (2.5%) |
590 (2.5%)* |
502 (3.4%) |
393 (3.2%)* |
17,988 (3.6%) |
| Total “Causes of death due to respiratory system” | 16,765 (21.2%)*f |
5079 (30.4%)* |
3442 (20.6%)* |
1482 (22.6%)* |
9866 (37.6%)* |
12,040 (33.0%)* |
25,486 (31.9%)* |
159 (25.1%) |
28,238 (42.7%)* |
2046 (30.4%)* |
10,434 (21.3%)* |
3392 (26.1%)* |
6338 (19.3%)* |
1837 (21.3%)* |
1061 (28.5%) |
123 (22.0%)* |
5836 (24.3%)* |
3751 (25.7%)* |
2505 (20.3%)* |
139,880 (28.3%) |
| 001-102 I-XXII. All Causes | 78,909 (16.0%)g | 16,680 (3.4%) | 16,725 (3.4%) |
6561 (1.3%) |
26,240 (5.3%) |
36,522 (7.4%) |
79,780 (16.2%) |
633 (0.1%) |
66,206 (13.4%) |
6738 (1.4%) |
49,033 (9.9%) |
12,994 (2.6%) |
32,879 (6.7%) |
8608 (1.7%) |
3727 (0.8%) |
560 (0.1%) |
24,041 (4.9%) |
14,578 (3.0%) |
12,362 (2.5%) |
493,776 (100.0%) |
| ICD-10 Causes of death | ≤18 years | 18–29 years | 30–39 years | 40–49 years | 50–59 years | 60–69 years | 70–79 years | 80–89 years | ≥90 years |
|---|---|---|---|---|---|---|---|---|---|
| (C) By age | |||||||||
| 00A Covid-19 Virus identified | 11 (0.7%)a |
53 (3.3%) |
129 (4.1%) |
508 (5.3%) |
1820 (6.9%) |
5141 (10.4%) |
12,491 (13.7%) |
24,872 (13.7%) |
15,333 (11.8%) |
| 00B Covid-19 Unidentified virus (suspected) | 3 (0.2%) |
14 (0.9%) |
20 (0.6%) |
75 (0.8%) |
275 (1.0%) |
590 (1.2%) |
1885 (2.1%) |
6139 (3.4%) |
5480 (4.2%) |
| 002 Tuberculosis and its late effects | 0 (0.0%) |
2 (0.1%) |
6 (0.2%) |
16 (0.2%) |
20 (0.1%) |
23 (0.0%) |
28 (0.0%) |
67 (0.0%) |
36 (0.0%) |
| 018 Malignant tumour of the trachea, bronchus and lung | 0 (0.0%) |
10 (0.6%) |
44 (1.4%) |
501 (5.2%) |
2851 (10.9%) |
6440 (13.0%) |
6838 (7.5%) |
4442 (2.5%) |
792 (0.6%) |
| 019 Other respiratory and intrathoracic malignant tumours | 2 (0.1%) |
4 (0.2%) |
9 (0.3%) |
22 (0.2%) |
51 (0.2%) |
103 (0.2%) |
155 (0.2%) |
141 (0.1%) |
15 (0.0%) |
| 062 Influenza (includes influenza due to identified pandemic or zoonotic influenza viruses) | 8 (0.5%) |
6 (0.4%) |
11 (0.3%) |
18 (0.2%) |
61 (0.2%) |
114 (0.2%) |
171 (0.2%) |
321 (0.2%) |
184 (0.1%) |
| 063 Pneumonia | 6 (0.4%) |
11 (0.7%) |
26 (0.8%) |
89 (0.9%) |
205 (0.8%) |
428 (0.9%) |
1199 (1.3%) |
3684 (2.0%) |
3120 (2.4%) |
| 064 Chronic lower respiratory tract diseases (except asthma) | 1 (0.1%) |
3 (0.2%) |
4 (0.1%) |
52 (0.5%) |
308 (1.2%) |
1188 (2.4%) |
2662 (2.9%) |
4834 (2.7%) |
2734 (2.1%) |
| 065 Asthma | 2 (0.1%) |
6 (0.4%) |
8 (0.3%) |
18 (0.2%) |
37 (0.1%) |
40 (0.1%) |
130 (0.1%) |
407 (0.2%) |
300 (0.2%) |
| 066 Respiratory insufficiency | 2 (0.1%) |
5 (0.3%) |
12 (0.4%) |
52 (0.5%) |
111 (0.4%) |
173 (0.3%) |
274 (0.3%) |
745 (0.4%) |
665 (0.5%) |
| 067 Other diseases of the respiratory system | 15 (0.9%) |
29 (1.8%) |
71 (2.2%) |
183 (1.9%) |
414 (1.6%) |
908 (1.8%) |
2483 (2.7%) |
7436 (4.1%) |
6449 (5.0%) |
| Total “Causes of death of the respiratory system” | 50 (3.1%)b |
143 (8.8%) |
340 (10.8%) |
1534 (16.0%) |
6153 (23.5%) |
15,148 (30.6%) |
28,316 (31.1%) |
53,088 (29.3%) |
35,108 (27.1%) |
| 001-102 I-XXII. All Causes | 1592 (0.3%)h |
1625 (0.3%) |
3159 (0.6%) |
9601 (1.9%) |
26,236 (5.3%) |
49,503 (10.0%) |
91,191 (18.5%) |
181,439 (36.7%) |
129,430 (26.2%) |
a
Percentage of each cause of death of the respiratory system compared to the total causes of death.
b
Percentage of all causes of death of the respiratory system compared to the total causes of death.
c
Percentage of all causes of death by year compared to the total for both genders.
d
Percentage of each cause of death of the respiratory system compared to total causes of death.
e
Significant differences (p < 0.01) are indicated by bold text.
f
Percentage of all causes of death of the respiratory system compared to all causes of death.
g
Percentage of all causes of death by year versus total causes of death in Spain.
h
Percentage of all causes of death according to age range compared to the total.